Skip to main content

Table 1 Predicted small molecules in connectivity mapping

From: m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma

rank

cmap name

enrichment

p

1

piperidolate

-0.945

0.00028

2

quinostatin

-0.902

0.01927

3

mecamylamine

-0.876

0.00387

4

prenylamine

-0.845

0.00103

5

bezafibrate

-0.835

0.00131

6

chrysin

-0.824

0.01084

7

crotamiton

-0.8

0.0031

8

ebselen

-0.797

0.01719

9

gliclazide

-0.791

0.00386

10

etomidate

-0.789

0.01909

11

CP-645525–01

-0.746

0.03333

12

canavanine

-0.732

0.03992

13

bethanechol

-0.703

0.01593

14

sulconazole

-0.682

0.02234

15

scoulerine

-0.673

0.02572

16

oxybutynin

-0.671

0.0261

17

epitiostanol

-0.67

0.02668

18

levocabastine

-0.657

0.03149

19

halcinonide

-0.65

0.01278

20

parbendazole

-0.648

0.03621

21

phenoxybenzamine

-0.638

0.04144

22

cyclopenthiazide

-0.631

0.04563

23

dosulepin

-0.627

0.04794

24

suloctidil

-0.623

0.04999

25

edrophonium chloride

-0.576

0.04117

26

amprolium

-0.576

0.04133

27

cefazolin

-0.568

0.04558

28

naloxone

-0.564

0.02576

29

cinchocaine

-0.562

0.04962

30

phenformin

-0.559

0.01335

31

metoclopramide

-0.524

0.04728

32

prochlorperazine

-0.511

0.00016